Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 121 participants.
Also called NCT05488431
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 121 participants
- Registry
-
NCT05488431
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05488431. Randomized; quadruple masking; primary purpose treatment. Start 2023-03-01 (actual); primary completion 2028-03-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
- Condition
- Dyslipidemias
- Condition
- Cardiovascular Diseases
- Condition
- HIV Infections
- Condition
- Atherosclerosis
- Intervention (Drug)
- Bempedoic acid
- Intervention (Other)
- Placebo
- Lead sponsor
- Priscilla Hsue, MD
- Collaborator
- University of California, Los Angeles
- Collaborator
- Massachusetts General Hospital
Record details
- Record id
cardio:ct-nct05488431- Content hash
00ef8da46a80d956dc1b1e2b41581cd748cf17917fb8e615c015ac97c0553818